Manzanera Andrea G - Advantagene, Inc

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 22 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Neoadjuvant CAN-2409 Plus Prodrug in Combination with Standard of Care Chemoradiation for Borderline Resectable Pancreatic Adenocarcinoma

William Nichols,Andrea Manzanera, Mark Bloomston, Vanessa Rosas-Camargo, Fidel David Huitzil-Melendez, Shangbang Rao, Jessica Dwyer, Francesca Barone, Paul Tak

crossref（2024）

引用0浏览0引用

Safety and Survival Outcomes in Recurrent High-Grade Glioma Patients Treated with CAN-3110, a First-in-Class ICP34.5 Expressing Oncolytic HSV1

Francesca Barone,Alexander Ling,Isaac H. Solomon,Ana Montalvo Landivar,Hiroshi Nakashima,Andrea Manzanera, Maria Lucia Silva Polanco,Andres Santos,Nafisa Masud,Patrick Wen, Keith Leigon,David Reardon,Sengupta Soma,Garrett Nichols,Paul Peter Tak,E. A. Chiocca

MOLECULAR THERAPYno. 5 (2023): 2-3

引用0浏览0引用

Clinical Trial Links Oncolytic Immunoactivation to Survival in Glioblastoma

Alexander L. Ling,Isaac H. Solomon,Ana Montalvo Landivar,Hiroshi Nakashima,Jared K. Woods,Andres Santos,Nafisa Masud,Geoffrey Fell,Xiaokui Mo,Ayse S. Yilmaz,James Grant,Abigail Zhang,Joshua D. Bernstock,Erickson Torio,Hirotaka Ito, Junfeng Liu,Naoyuki Shono,Michal O. Nowicki,Daniel Triggs, Patrick Halloran,Raziye Piranlioglu,Himanshu Soni,Brittany Stopa,Wenya Linda Bi,Pierpaolo Peruzzi,Ethan Chen,Seth W. Malinowski, Michael C. Prabhu,Yu Zeng,Anne Carlisle,Scott J. Rodig,Patrick Y. Wen,Eudocia Quant Lee,Lakshmi Nayak,Ugonma Chukwueke,L. Nicolas Gonzalez Castro, Sydney D. Dumont,Tracy Batchelor, Kara Kittelberger,Ekaterina Tikhonova,Natalia Miheecheva,Dmitry Tabakov,Nara Shin, Alisa Gorbacheva,Artemy Shumskiy,Felix Frenkel,Estuardo Aguilar-Cordova,Laura K. Aguilar,David Krisky,James Wechuck,Andrea Manzanera,Chris Matheny,Paul P. Tak,Francesca Barone, Daniel Kovarsky,Itay Tirosh,Mario L. Suvà,Kai W. Wucherpfennig,Keith Ligon,David A. Reardon,E. Antonio Chiocca

Nature（2023）

引用11浏览0WOSNATURE引用

CAN-2409 Plus Prodrug with Standard of Care Immune Checkpoint Inhibitor for Patients with Stage III/IV NSCLC

Charu Aggarwal,Daniel Sterman,Fabien Maldonado,Christine M. Bestvina,Janani S. Reisenauer,Howard Li,Sonam Puri, Omar Ibrahim, Randy Swan, Audra Caine,Lenika Lopez,Andrea G. Manzanera,Francesca Barone, Christopher Jon Matheny,William Garrett Nichols,Paul Peter Tak

Journal of clinical oncologyno. 16_suppl (2023): TPS9162-TPS9162

引用0浏览0引用

1477 First efficacy and multi-omic analysis data from phase 1 clinical trial of oncolytic viral immunotherapy with CAN-2409 + valacyclovir in combination with nivolumab and standard of care in newly diagnosed high-grade glioma

Late-Breaking Abstracts (2022): A1535-A1535

引用0浏览0引用

First Report of Safety/tolerability and Preliminary Antitumor Activity of CAN-2409 in Inadequate Responders to Immune Checkpoint Inhibitors for Stage III/IV NSCLC

Charu Aggarwal,Andrew Haas,Sarah W. Gordon,Ranee Mehra,Peter M. Lee,Christine M. Bestvina,Fabien Maldonado,Vamsidhar Velcheti,Roy S. Herbst,Susan D. Bell, Rachael Gillmor,Andrea Manzanera, Christopher Jon Matheny,Estuardo Aguilar-Cordova,Laura K. Aguilar,Francesca Barone,Paul Peter Tak,Daniel Sterman

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用2浏览0引用

1477 First Efficacy and Multi-Omic Analysis Data from Phase 1 Clinical Trial of Oncolytic Viral Immunotherapy with CAN-2409 + Valacyclovir in Combination with Nivolumab and Standard of Care in Newly Diagnosed High-Grade Glioma

openalex（2022）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn